Mirae Asset Global Investments’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-35,670
Closed -$1.09M 1848
2024
Q1
$1.09M Sell
35,670
-14,389
-29% -$459K ﹤0.01% 1494
2023
Q4
$1.65M Sell
50,059
-716
-1% -$20.3K ﹤0.01% 1345
2023
Q3
$1.38M Hold
50,775
﹤0.01% 1361
2023
Q2
$1.54M Buy
50,775
+15,105
+42% +$488K ﹤0.01% 1346
2023
Q1
$1.16M Buy
35,670
+483
+1% +$15.3K ﹤0.01% 1463
2022
Q4
$988K Buy
35,187
+499
+1% +$14.3K ﹤0.01% 1502
2022
Q3
$1.25M Buy
34,688
+11,073
+47% +$390K ﹤0.01% 1364
2022
Q2
$725K Buy
+23,615
New +$688K ﹤0.01% 1573
2021
Q4
Sell
-467,429
Closed -$14.5M 1635
2021
Q3
$14.5M Sell
467,429
-90,501
-16% -$2.17M 0.04% 501
2021
Q2
$11.8M Sell
557,930
-12,244
-2% -$245K 0.03% 576
2021
Q1
$11.5M Buy
570,174
+165,872
+41% +$3.15M 0.04% 495
2020
Q4
$6.48M Buy
404,302
+167,422
+71% +$2.21M 0.02% 597
2020
Q3
$2.94M Buy
+236,880
New +$2.79M 0.01% 681

Other funds holding EVH

Mirae Asset Global Investments's EVH Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Evolent Health (EVH) in Q2 2024, closing a stake of 35,670 shares — an estimated $1.09M sold.

Mirae Asset Global Investments first reported a position in EVH in Q3 2020 and held it in 13 quarters. The position peaked at $14.5M in Q3 2021. 243 funds tracked by Wall St. Rank hold EVH as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining Evolent Health position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 35,670 Evolent Health shares in Q2 2024, an estimated $1.09M.
  • Mirae Asset Global Investments first reported a position in Evolent Health in Q3 2020 and held it in 13 quarters.
  • Mirae Asset Global Investments's Evolent Health position peaked at $14.5M in Q3 2021.
  • 243 funds tracked by Wall St. Rank held Evolent Health as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.